Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mandy Sakamoto

Concepts (54)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
5
2024
1186
1.310
Why?
Lung Neoplasms
5
2024
2660
0.960
Why?
Benzodiazepines
1
2021
168
0.600
Why?
Lactams, Macrocyclic
1
2018
51
0.560
Why?
Organophosphorus Compounds
1
2018
84
0.530
Why?
Central Nervous System
1
2018
279
0.480
Why?
Pyrimidines
2
2024
519
0.480
Why?
Analgesics, Opioid
1
2021
1142
0.360
Why?
Antineoplastic Agents
2
2021
2201
0.330
Why?
Breast Neoplasms
1
2021
2365
0.270
Why?
Pemetrexed
1
2024
39
0.220
Why?
Acrylamides
1
2024
73
0.210
Why?
Mutation
3
2024
4081
0.200
Why?
Aniline Compounds
1
2024
121
0.200
Why?
Proto-Oncogene Proteins c-met
1
2023
76
0.180
Why?
B7-H1 Antigen
1
2023
242
0.160
Why?
Neoplasm Metastasis
2
2024
691
0.160
Why?
SEER Program
1
2021
226
0.150
Why?
Lactams
1
2018
28
0.140
Why?
Drug Approval
1
2018
91
0.140
Why?
Molecular Targeted Therapy
1
2021
437
0.140
Why?
Protein-Tyrosine Kinases
1
2021
431
0.140
Why?
Aminopyridines
1
2018
129
0.130
Why?
Proto-Oncogene Proteins
1
2021
619
0.130
Why?
Antibodies, Monoclonal, Humanized
1
2023
990
0.120
Why?
Protein Kinase Inhibitors
1
2023
971
0.120
Why?
Recurrence
1
2018
1136
0.110
Why?
Medicare
1
2021
899
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1961
0.110
Why?
Pyrazoles
1
2018
512
0.110
Why?
Opioid-Related Disorders
1
2021
601
0.090
Why?
Dermatology
1
2012
128
0.080
Why?
Humans
7
2024
144665
0.080
Why?
Retrospective Studies
2
2024
17147
0.060
Why?
Referral and Consultation
1
2012
852
0.060
Why?
Treatment Outcome
2
2018
11734
0.060
Why?
United States
2
2021
16018
0.050
Why?
Telemedicine
1
2012
957
0.050
Why?
ErbB Receptors
1
2024
632
0.040
Why?
Indoles
1
2024
504
0.040
Why?
Adult
2
2024
40486
0.040
Why?
Disease Progression
1
2024
2847
0.030
Why?
Female
2
2024
78301
0.030
Why?
Male
2
2024
72425
0.030
Why?
Drug Resistance, Neoplasm
1
2021
881
0.030
Why?
Northwestern United States
1
2012
58
0.020
Why?
Health Records, Personal
1
2012
26
0.020
Why?
Aged, 80 and over
1
2024
8283
0.020
Why?
Medically Underserved Area
1
2012
100
0.020
Why?
Remote Consultation
1
2012
66
0.020
Why?
Rural Health Services
1
2012
139
0.020
Why?
Aged
1
2024
25955
0.010
Why?
Middle Aged
1
2024
35968
0.010
Why?
Veterans
1
2012
1614
0.010
Why?
Sakamoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)